Companies in #Osteoarthritis
Found 2 companies operating in this sector.
Olatec Therapeutics
PrivateClinical-stage biotech developing oral NLRP3 inflammasome inhibitors, led by dapansutrile (OLT1177), which has advanced from discovery into later-stage clinical development across inflammatory and age-related diseases.
Pacira BioSciences is a specialty pharmaceutical company focused on the development, manufacture and commercialization of non-opioid pain management and regenerative health solutions. Its commercial portfolio includes EXPAREL (bupivacaine liposome injectable suspension) for postsurgical pain, ZILRETTA (triamcinolone acetonide extended-release injectable suspension) for osteoarthritis knee pain, and the iovera system, a handheld cryoanalgesia device. On October 8, 2026, Viatris agreed to acquire Pacira for $36.50 per share in cash in a transaction valued at approximately $1.65 billion.